|
|
.
See Category: Neoplasms
See Header: Malignant neoplasm of upper-inner quadrant of breast, female
ICD-10 (CM) Code and Descriptor
|
C50.211 |
Malignant neoplasm of upper-inner quadrant of right female breast
Diagnosis Valid for Female Patient Only
|
C50211 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 63.15%
|
24.26%
|
5.97%
|
2.75%
|
1.38%
|
0.89%
|
0.50%
|
0.30%
|
0.23%
|
0.17%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for C50.211*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
19,295
|
19,408
|
|
80053
|
COMPREHEN METABOLIC PANEL |
13,034
|
13,034
|
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
12,857
|
12,860
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
10,878
|
10,905
|
|
77412
|
RADIATION TX DELIVERY COMPLX |
10,832
|
10,847
|
|
86300
|
IMMUNOASSAY TUMOR CA 15-3 |
4,233
|
4,576
|
|
88307
|
TISSUE EXAM BY PATHOLOGIST |
3,778
|
8,566
|
|
G0279
|
TOMOSYNTHESIS, MAMMO |
3,321
|
3,321
|
|
J3010
|
FENTANYL CITRATE INJECTION |
3,032
|
5,516
|
|
88305
|
TISSUE EXAM BY PATHOLOGIST |
2,943
|
4,795
|
|
J2405
|
ONDANSETRON HCL INJECTION |
2,935
|
15,900
|
|
88342
|
IMHCHEM/IMCYTCHM 1ST ANTB |
2,756
|
4,113
|
|
J1100
|
DEXAMETHASONE SODIUM PHOS |
2,737
|
22,742
|
|
77065
|
DX MAMMO INCL CAD UNI |
2,721
|
2,726
|
|
J2704
|
INJ, PROPOFOL, 10 MG |
2,624
|
86,312
|
|
77387
|
GUIDANCE FOR RADJ TX DLVR |
2,564
|
2,565
|
|
77066
|
DX MAMMO INCL CAD BI |
2,539
|
2,539
|
|
J0690
|
CEFAZOLIN SODIUM INJECTION |
2,466
|
9,789
|
|
77336
|
RADIATION PHYSICS CONSULT |
2,268
|
2,269
|
|
19301
|
PARTIAL MASTECTOMY |
2,130
|
2,131
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
C50.211 related to the following DRG Codes:
582-583
597-599
|
